I/VC  Forward Ventures

http://www.forwardventures.com





     Office Locations:

4747 Executive Dr., Suite 700
San Diego, CA 92121
Phone: 858-677-6077
Fax: 858-452-8799

 

Stages:

  • Early
  • Seed


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Founded in 1993, Forward Ventures has invested in over 50 companies and currently has approximately $500 million in capital under management. The most recent fund, Forward V, continues Forward Ventures' program of life sciences (including pharmaceuticals and related opportunities but not software or medical services), and health care (including medical devices). The firm is headquartered in a 40,000 square-foot research building that also serves as an incubator for its portfolio companies. Forward invests in companies of all stages of development in North America and will consider select European opportunities. Forward's typical investment size ranges from $1 to $6 million (initially), and $3 to $15 million over the total lifespan of the investment. The firm's Forward Pacific Ventures team focuses on China opportunities.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or Southern California Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Southern California Database subscription.
    Ivor Royston MD Managing Member
    Kristen Bailey Director of Finance & Administration
    Mang (Mark) Yu Managing Partner
    Standish Fleming Managing Member
    Stuart J.M. Collinson PhD Key Voting Member

     

    Portfolio companies include:


      Acorda Therapeutics
        web link


      Affinium Pharmacueticals
        web link


      Ambit Biosciences
        web link


      Asteres
        web link


      Avalon Pharmaceuticals
        web link


      Cabrellis Pharmaceuticals
        web link


      Dynavax
        web link


      Essentials Therapeutics
        web link


      HemaQuest Pharmacueticals
        web link


      Ligocyte Pharmacueticals
        web link


      Micromet
        web link


      MMR Information Systems
        web link


      Nereus
        web link


      NovaCardia
        web link


      NovoStent
        web link


      Proprius Pharmacueticals
        web link


      Sequel Pharmacueticals
        web link


      Syndax Pharmaceuticals
        web link


      Tioga Pharmaceuticals
        web link


      Viracta Therapeutics
        web link


     

    Recent News: